BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12239212)

  • 1. Inhibition of Wilms tumor 1 transactivation by bone marrow zinc finger 2, a novel transcriptional repressor.
    Lee TH; Lwu S; Kim J; Pelletier J
    J Biol Chem; 2002 Nov; 277(47):44826-37. PubMed ID: 12239212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
    Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
    Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A structure-function analysis of transcriptional repression mediated by the WT1, Wilms' tumor suppressor protein.
    Madden SL; Cook DM; Rauscher FJ
    Oncogene; 1993 Jul; 8(7):1713-20. PubMed ID: 8510918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA binding by the Wilms tumor suppressor zinc finger proteins.
    Caricasole A; Duarte A; Larsson SH; Hastie ND; Little M; Holmes G; Todorov I; Ward A
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7562-6. PubMed ID: 8755514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WT1 and DAX-1 inhibit aromatase P450 expression in human endometrial and endometriotic stromal cells.
    Gurates B; Sebastian S; Yang S; Zhou J; Tamura M; Fang Z; Suzuki T; Sasano H; Bulun SE
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4369-77. PubMed ID: 12213901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Wilms' tumor suppressor gene (wt1) product represses different functional classes of transcriptional activation domains.
    Lee TH; Moffett P; Pelletier J
    Nucleic Acids Res; 1999 Jul; 27(14):2889-97. PubMed ID: 10390530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
    Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression in Xenopus oocytes shows that WT1 binds transcripts in vivo, with a central role for zinc finger one.
    Ladomery M; Sommerville J; Woolner S; Slight J; Hastie N
    J Cell Sci; 2003 Apr; 116(Pt 8):1539-49. PubMed ID: 12640038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wilms' tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation.
    Kim J; Prawitt D; Bardeesy N; Torban E; Vicaner C; Goodyer P; Zabel B; Pelletier J
    Mol Cell Biol; 1999 Mar; 19(3):2289-99. PubMed ID: 10022915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
    Madden SL; Cook DM; Morris JF; Gashler A; Sukhatme VP; Rauscher FJ
    Science; 1991 Sep; 253(5027):1550-3. PubMed ID: 1654597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High affinity binding sites for the Wilms' tumour suppressor protein WT1.
    Hamilton TB; Barilla KC; Romaniuk PJ
    Nucleic Acids Res; 1995 Jan; 23(2):277-84. PubMed ID: 7862533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
    Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
    Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1.
    Goodyer P; Dehbi M; Torban E; Bruening W; Pelletier J
    Oncogene; 1995 Mar; 10(6):1125-9. PubMed ID: 7700638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.
    Johnstone RW; See RH; Sells SF; Wang J; Muthukkumar S; Englert C; Haber DA; Licht JD; Sugrue SP; Roberts T; Rangnekar VM; Shi Y
    Mol Cell Biol; 1996 Dec; 16(12):6945-56. PubMed ID: 8943350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Wilms' tumor suppressor Wt1 encodes a transcriptional activator of the class IV POU-domain factor Pou4f2 (Brn-3b).
    Wagner KD; Wagner N; Schley G; Theres H; Scholz H
    Gene; 2003 Feb; 305(2):217-23. PubMed ID: 12609742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional interaction with CBP contributes to transcriptional activation by the Wilms tumor suppressor WT1.
    Wang W; Lee SB; Palmer R; Ellisen LW; Haber DA
    J Biol Chem; 2001 May; 276(20):16810-6. PubMed ID: 11278547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
    Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
    J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter.
    Webster NJ; Kong Y; Sharma P; Haas M; Sukumar S; Seely BL
    Biochem Mol Med; 1997 Dec; 62(2):139-50. PubMed ID: 9441865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product, WT1.
    Matsuzawa-Watanabe Y; Inoue J; Semba K
    Oncogene; 2003 Sep; 22(39):7900-4. PubMed ID: 12970737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation.
    Song KH; Park YY; Park KC; Hong CY; Park JH; Shong M; Lee K; Choi HS
    Mol Endocrinol; 2004 Aug; 18(8):1929-40. PubMed ID: 15155786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.